Omega-3 Fatty Acid Supplements for Chronic Epilepsy

J Gordon Millichap

doi:10.15844/pedneurbriefs-19-9-6

Omega-3 Fatty Acid Supplements for Chronic Epilepsy

Pediatric Neurology Briefs

Volume 19 (2005): Issue 9

By: J Gordon Millichap

Open Access

|Sep 2005

Abstract

Omega-3 fatty acid (FA) supplements (lg EPA and 0.7g DHA daily) were used in the treatment of 58 patients with refractory epilepsy, in a 12-week double-blind, placebo-controlled trial conducted by researchers at the UCL Institute of Neurology, London, UK.

References

Yuen AW Sander JW Fluegel D Patsalos PN Bell GS Johnson T Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial Epilepsy Behav 2005 September 7 2 253 258 10.1016/j.yebeh.2005.04.014 16006194
Open DOI Search in Google Scholar Back to article
Bailey EE Pfeifer HH Thiele EA The use of diet in the treatment of epilepsy Epilepsy Behav 2005 Feb 6 1 4 8 10.1016/j.yebeh.2004.10.006 15652725
Open DOI Search in Google Scholar Back to article
Richardson AJ Montgomery P The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder Pediatrics 2005 May 115 5 1360 1366 10.1542/peds.2004-2164 15867048
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-19-9-6 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 69 - 69

Published on: Sep 1, 2005

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Fatty Acid,

Antiepileptic Drug,

Experimental Studies

© 2005 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 19 (2005): Issue 9